Find companies:

Affymax, Inc

Job Work/Life Balance
Job Security/Advancement
Job Culture
1 review

About Affymax, Inc

Affymax, Inc. is a biopharmaceutical company developing peptide-based drugs to improve the treatment of serious and often life-threatening conditions. The Company's product candidate, Hematide, is designed to treat anemia associated with chronic renal failure. Hematide is a relatively small synthetic peptide-based erythropoiesis stimulating agent (ESA), – more... which it is developing for the treatment of anemia patients with chronic renal failure. The Company is conducting Phase III clinical trials in patients suffering from chronic renal renal failure, on dialysis and not on dialysis (pre-dialysis). In August 2008, the Company and Takeda Pharmaceutical Company Limited (Takeda), agreed to suspend development of Hematide to treat chemotherapy induced anemia.
(Source: 10-K) – lessMore from ZoomInfo »

Affymax, Inc Employer Reviews

Senior Scientist II, Senior Scientist (Former Employee), Palo Alto, CADecember 6, 2013